Programme no. 306-SY
Public Health
Statins for many. How many?
Jan Håkansson*1, Halfdan Petursson*2, Hans Blomberg*3, Peter Nilsson*4
1Krokoms HC,Krokom,Sweden, 2Institutt for samfunnsmedisin,Norges Teknisk-Naturvitenskapelige Universitet,Trondheim,Norway, 3,Sibbo health center,Sibbo,Finland, 4,Institutionen för kliniska vetenskaper; VO internmedicin,Malmö,Sweden
* = Presenting author
Symposium
Objectives: To scrutinize new guidelines for statin treatment and their consequences for people at risk for cardiovascular disease. Potential changes in primary health care work.
Background: Evidence for beneficial effects of statins to prevent cardiovascular disease have emerged the last decades. Recently updated guidelines broaden indications for statin treatment, particularly for primary prevention. These guidelines have large consequences for healthy people at risk for cardiovascular disease and for primary health care and are lively debated.
Content:
Method: Lectures and discussion
Other considerations: -